CNS Therapeutics Market: Introduction
- Central nervous system (CNS) is an integral part of the nervous system that comprises brain and spinal cord. The primary function of CNS is to integrate the information received, and help in coordination of and controlling body activities.
- Diseases, such as autoimmune and inflammatory disorders, genetic disorders, cancers, and neurodegenerative diseases, affect the functionality of the spinal cord
- CNS therapeutic drugs are used for the treatment of these disorders
Key Drivers of Global CNS Therapeutics Market
- The global CNS therapeutics market is likely to be driven by the rise in ageing population, high prevalence of these disorders, and growth in the awareness about CNS therapeutics diseases. According to the National Institute on Aging, almost 524 million individuals, approximately 8% of the global population, were above the age of 65 in 2010. This number is expected to reach 1.5 billion, which is almost 16% of the global population, by 2050. The rate of incidence of CNS diseases increases with advancing age.
- Governments as well as non-government organizations across the globe are taking various initiatives to raise awareness about CNS disorders. Organizations are also raising funds to support clinical research & development for better treatment of the disease. For instance, April 11 is observed as World Parkinson's Day every year.
Planning To Lay Down Future Strategy? Request Brochure Of CNS Therapeutics Market
- Unmet needs for the treatment of CNS disease are high. In order to fuel research and clinical developments in these disorders, governments, non-profit organizations, and pharmaceutical and biotechnology companies across the globe have allocated and increased their research funding budget over a period of time. This factor is expected to fuel the market growth during the forecast period.
- CNS therapeutics can be regarded as most important. There has been market growth with the introduction of various therapies due to novel mechanism of action, such as serotonin and norepinephrine reuptake inhibitors (SNRIs).
- Patent expiry of drugs, however, is likely to affect the overall market growth during the forecast period
North America to Hold Major Share of Global CNS Therapeutics Market
- North America is projected to lead the market for CNS therapeutics during the forecast period. Factors, such as high number of reported cases of depression and anxiety as well as adoption of advanced therapeutics, are expected to fuel market growth.
- Awareness campaigns and conferences about identification and treatment of CNS diseases, which include mental diseases, are being organized by leading pharma companies and/or rehabilitation centers. This factor is expected to propel the number of patients opting for early diagnosis.
- CNS therapeutics market in Asia Pacific is anticipated to witness significant growth due to high rate of prevalence of neurodegenerative disorders, rise in awareness regarding mental health, and improvements in healthcare facilities. In developing countries, such as India and China, a large number of non-government organizations are offering cost-effective treatments to people with Alzheimer’s and Parkinson’s disease. This factor is anticipated to propel the demand for CNS drugs in the region during the forecast period.
To Obtain All-Inclusive Information On Forecast Analysis Of CNS Therapeutics Market , Request A Discount
Key Players Operating in Global Market
Major players operating in the global CNS therapeutics market are:
- Pfizer, Inc.
- Eli Lilly and Company, Inc.
- Biogen, Inc.
- GlaxoSmithKline plc
- Otsuka Pharmaceutical Co., Ltd.
- Johnson & Johnson Services, Inc.
- Merck & Co., Inc.
- Novartis AG
More Trending Reports by Transparency Market Research –
Invisible Orthodontics Market–
Request For N99 Face Mask Market Analysis –
No comments:
Post a Comment